slot gacor slot gacor hari ini slot gacor 2025 demo slot pg slot gacor slot gacor
HUBUNGAN KONSUMSI IKAN TERHADAP RISIKO SINDROM METABOLIK PADA WANITA OBESITAS ABDOMINAL | Noer | Journal of Nutrition College skip to main content

HUBUNGAN KONSUMSI IKAN TERHADAP RISIKO SINDROM METABOLIK PADA WANITA OBESITAS ABDOMINAL

Departemen Ilmu Gizi, Fakultas Kedokteran, Universitas Diponegoro, Indonesia

Received: 19 Oct 2020; Published: 19 Nov 2020.

Citation Format:
Abstract

Latar belakang: Obesitas abdominal dikaitkan dengan sindrom metabolic yang dikombinasikan dengan dislipidemia, intoleransi glukosa, dan hipertensi. Obesitas abdominal muncul untuk mendahului munculnya komponen sindrom metabolik lainnya, dipicu oleh kenaikan berat badan, terutama peningkatan penumpukan lemak perut. Ikan merupakan sumber protein hewani yang bergizi. Konsumsi ikan diketahui dapat menjadi pangan fungsional dengan cara melindungi terhadap beberapa jenis penyakit.

Tujuan: Mengetahui hubungan antara asupan ikan dalam seminggu dengan sindrom metabolik dan komponennya pada wanita obesitas abdominal, diharapkan bahwa konsumsi ikan yang lebih tinggi dikaitkan dengan risiko sindrom metabolic yang lebih rendah dan profil metabolisme yang lebih baik

Metode: Penelitian ini merupakan penelitian observatif dengan desain cross–sectional dan teknik pengambilan sampel purposive sampling sebanyak 88 wanita yang mengalami obesitas abdominal. Pengumpulan data dilakukan setelah melakukan puasa selama 12 jam sebelum pemeriksaan dan asupan ikan diperolah dari FFQ. Uji hubungan dilakukan dengan menggunakan korelasi Pearson.

Hasil: Terdapat hubungan bermakna antara konsumsi ikan dalam seminggu dengan komponen sindrom metabolic seperti GDP (p < 0,001, r=-0,376), kolesterol total (p < 0,05, r=-0,270), HDL (p < 0,001, r=0,349), LDL (p < 0,001, r= -0.421) dan LBTB (p < 0,001, r=-0,856) dengan korelasi positif dan sangat kuat. Terdapat 53,4% subjek mengonsumsi ikan 1-3 kali/minggu.

Simpulan: Konsumsi ikan memiliki korelasi positif dengan komponen sindrom metabolic. Penggantian sumber lemak jenuh menjadi lemak n-3 dapat menjadi efek terapeutik untuk perbaikan sindrom metabolik, namun diikuti dengan jangka waktu yang lama

Fulltext View|Download
Keywords: konsumsi ikan; sindrom metabolik; wanita; obesitas abdominal; AHA-DHA

Article Metrics:

  1. Kreissl A, Jorda A, Truschner K, Skacel G, Greber-Platzer S. Clinically relevant body composition methods for obese pediatric patients. BMC Pediatr. 2019;19(1):1–8
  2. Hu L, Huang X, You C, Li J, Hong K, Li P, et al. Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PLoS One. 2017;12(9):1–14
  3. Kabwama SN, Kirunda B, Mutungi G, Wesonga R, Bahendeka SK, Guwatudde D. Prevalence and correlates of abdominal obesity among adults in Uganda: findings from a national cross-sectional, population based survey 2014. BMC Obes. 2018;5(1):1–9
  4. Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016
  5. Sigit FS, Tahapary DL, Trompet S, Sartono E, Willems Van Dijk K, Rosendaal FR, et al. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: A cross-sectional analysis of two population-based studies. Diabetol Metab Syndr [Internet]. 2020;12(1):1–11
  6. Ruidavets JB, Bongard V, Dallongeville J, Arveiler D, Ducimetière P, Perret B, et al. High consumptions of grain, fish, dairy products and combinations of these are associated with a low prevalence of metabolic syndrome. J Epidemiol Community Health. 2007;61(9):810–7
  7. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: The atherosclerosis risk in communities study. Circulation. 2008;117(6):754–61
  8. Zaribaf F, Falahi E, Barak F, Heidari M, Keshteli AH, Yazdannik A, et al. Fish consumption is inversely associated with the metabolic syndrome. Eur J Clin Nutr. 2014;68(4):474–80
  9. Tørris C, Molin M, Cvancarova MS. Lean fish consumption is associated with lower risk of metabolic syndrome: A Norwegian cross sectional study. BMC Public Health. 2016;16(1):1–9
  10. Lee KK, Park HS, Yum KS. Cut-off values of visceral fat area and waist-to-height ratio: Diagnostic criteria for obesity-related disorders in Korean children and adolescents. Yonsei Med J. 2012;53(1):99–105
  11. Baik I, Abbott RD, Curb JD, Shin C. Intake of Fish and n-3 Fatty Acids and Future Risk of Metabolic Syndrome. J Am Diet Assoc. 2010;110(7):1018–26
  12. Tørris C, Småstuen MC, Molin M. Nutrients in fish and possible associations with cardiovascular disease risk factors in metabolic syndrome. Nutrients. 2018;10(7):1–17
  13. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: Effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr. 1999;70(5):817–25
  14. Helland A, Bratlie M, Hagen I V., Mjos SA, Sornes S, Ingvar Halstensen A, et al. High intake of fatty fish, but not of lean fish, improved postprandial glucose regulation and increased the n-3 PUFA content in the leucocyte membrane in healthy overweight adults: A randomised trial. Br J Nutr. 2017;117(10):1368–78
  15. Van Woudenbergh GJ, Van Ballegooijen AJ, Kuijsten A, Sijbrands EJG, Van Rooij FJA, Geleijnse JM, et al. Eating fish and risk of type 2 diabetes: A population-based, prospective follow-up study. Diabetes Care. 2009;32(11):2021–6
  16. Wistar M, Lipoprotein HD. Effect of fatty Amazon fish consumption on lipid metabolism Efeito do consumo de peixes amazônicos gordurosos sobre o metabolismo lipídico. 2014;27(1):97–105
  17. Zibaeenezhad MJ, Ghavipisheh M, Attar A, Aslani A. Comparison of the effect of omega-3 supplements and fresh fish on lipid profile: A randomized, open-labeled trial. Nutr Diabetes . 2017;7(12):1–8
  18. Yates A, Norwig J, Maroon JC, Bost J, Bradley JP, Duca M, et al. Evaluation of lipid profiles and the use of omega-3 essential fatty acid in professional football players. Sports Health. 2009;1(1):21–30
  19. Qin Y, Zhou Y, Chen SH, Zhao XL, Ran L, Zeng XL, et al. Fish oil supplements lower serum lipids and glucose in correlation with a reduction in plasma fibroblast growth factor 21 and prostaglandin E2 in nonalcoholic fatty liver disease associated with hyperlipidemia: A randomized clinical trial. PLoS One. 2015;10(7):1–13
  20. Wei MY, Jacobson TA. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: A systematic review and meta-analysis. Curr Atheroscler Rep. 2011;13(6):474–83
  21. Yoo EG. Waist-to-height ratio as a screening tool for obesity and cardiometabolic risk. Korean J Pediatr. 2016;59(11):425–31
  22. Ramel A, Jonsdottir MT, Thorsdottir I. Consumption of cod and weight loss in young overweight and obese adults on an energy reduced diet for 8-weeks. Nutr Metab Cardiovasc Dis. 2009;19(10):690–6
  23. Du S, Jin J, Fang W, Su Q. Does fish oil have an anti-obesity effect in overweight/obese adults? A meta-analysis of randomized controlled trials. PLoS One. 2015;10(11):1–20
  24. Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet: New insights. Circulation. 2011;123(24):2870–91

Last update:

No citation recorded.

Last update:

No citation recorded.